PTPRC and colorectal cancer: Notably, this cell-killing effect of B220 was more prominent in HCT116 colorectal cancer cells than in prostate cancer PC3 and non-small-cell lung cancer A549 cells (Fig. 1A and B), making HCT116 cells an appropriate model for assessing the effects of B220 and its underlying molecular mechanism of action.